JosephMelnik (Joe)

Partner

Silicon Valley + 1.650.687.4151

Joe Melnik's practice is focused on technology licensing, technology commercialization, and other technology-related transactions. Joe counsels clients on complex transactions related to a broad range of technologies including software, semiconductors, energy, data and network security, and consumer devices. He negotiates and structures license agreements, joint ventures, joint development agreements, strategic alliances, services, supply, and various other agreements for domestic and global projects. Joe also advises companies of all sizes on the development and implementation of strategies for maximizing the benefits of technology transactions; advising on intellectual property issues that arise in connection with corporate transactions, such as mergers and acquisitions; and assisting clients in developing domestic and international product commercialization strategies that utilize intellectual property positions to protect and expand market share.

Joe also represents clients in patent litigation, license disputes, and post-grant proceedings. He has successfully represented companies in patent cases relating to a wide variety of technologies, including cryptography, smart cards, biometrics, cellular telephony, SMS, computer networking, wireless communications, semiconductors, database technologies, and financial transactions. In addition, he frequently represents companies in high-stakes licensing disputes in a broad range of technology areas and has been lead counsel on numerous IPR proceedings before the Patent Trial and Appeal Board.

Joe's practice further includes the development and management of patent portfolios, freedom-to-practice opinions, and strategic counseling. In this role, he counsels clients developing robust intellectual property portfolios, mining portfolios for key assets, and managing a company's intellectual capital to maximize commercial benefits while minimizing risks and costs.

Experiência

  • Sequential Technology International sold to APC HoldingsJones Day advised Sequential Technology International LLC, an innovative leader in the software, consulting, and BPO sectors, in its sale to APC Holdings.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • Synaptics divests LCD TDDI business to Hua Capital for $139.4 millionJones Day advised Synaptics Incorporated in its $139.4 million divestiture of its Asia-based mobile LCD TDDI Business to an affiliate of Hua Capital.
  • Hitachi Vantara acquires Waterline Data, Inc.Jones Day advised Hitachi Vantara LLC, a wholly owned subsidiary of Hitachi, Ltd., in its acquisition of all of the assets of Waterline Data, Inc., a U.S.-based company that provides intelligent data cataloging solutions for DataOps that help customers more easily gain actionable insights from large datasets and comply with data regulations.
  • Western Digital sold ActiveScale™ business to QuantumJones Day advised Western Digital Corporation's subsidiary Western Digital Technologies, Inc. in the sale of its ActiveScale™ business to Quantum Corporation.
  • Hitachi Vantara acquires ContainerShip, Inc.Jones Day advised Hitachi Vantara LLC in its acquisition of assets from ContainerShip, Inc., a start-up company specializing in the Kubernetes open-source platform space.
  • Resonant Therapeutics enters into strategic alliance with Retrogenix to identify targets of anti-tumor antibodiesJones Day represented Resonant Therapeutics, Inc. in a strategic alliance with Retrogenix to identify the targets of Resonant antibodies directed against the tumor microenvironment.
  • Resonant Therapeutics enters into target discovery and therapeutic validation collaboration agreement with JanssenJones Day represented Resonant Therapeutics, Inc. in an agreement with Janssen Research and Development, LLC with the aim to discover and validate novel tumor and immunological targets and to validate certain therapeutic candidates.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Western Digital sells IntelliFlash™ business to DataDirect Networks, Inc. (DDN®)Jones Day advised Western Digital Corp. in the sale of its IntelliFlash™ business to DataDirect Networks, Inc. (DDN®), a global leader in artificial intelligence (AI) and multi-cloud data management.
  • SunPower announces sponsored spin-off of solar panel production operationsJones Day is advising SunPower Corporation (NASDAQ: SPWR), one of North America's largest solar-panel makers, in a sponsored spin-off of its solar panel production operations into a new public company – Maxeon Solar Technologies – which will be headquartered in Singapore.
  • Modern Media Acquisition completes merger agreement with Akazoo Ltd.Jones Day advised Modern Media Acquisition Corp. ("MMDM"), a special purpose acquisition company, in its business combination with Akazoo Limited, a U.K.- based digital music streaming platform specializing in emerging markets.
  • Educational Testing Service invests $2 million into LearnLaunch-operated, ETS-sponsored accelerator for education start-upsJones Day advised Educational Testing Service in its $2 million investment into a LearnLaunch-operated, ETS-sponsored accelerator for education start-ups.
  • Evidera acquires MedimixJones Day advised Evidera, a business unit of Pharmaceutical Product Development, LLC, in its acquisition of Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic, and medical device industries.
  • Drive.ai sold to Apple Inc.Jones Day advised Drive.ai in the sale of substantially all of its assets to Apple Inc.
  • KKR completes investment in OneStream SoftwareJones Day advised Kohlberg Kravis Roberts & Co. L.P. in connection with its investment in OneStream Software LLC, a leading provider of cloud or on-premise Corporate Performance Management solutions for mid-sized to large enterprises, in a transaction that values the privately held company at more than $1 billion.
  • Cylance acquired by BlackBerry for $1.4 billionJones Day advised Cylance, an artificial intelligence and cybersecurity leader, in its $1.4 billion acquisition by BlackBerry Limited, plus the assumption of unvested employee incentive awards.
  • Adtalem Global Education sells DeVry UniversityJones Day advised Adtalem Global Education in the sale of DeVry University and its Keller Graduate School of Management to Cogswell Education, LLC, a company with significant experience in higher education.
  • Oclaro sold to Lumentum for $1.8 billion in cash and stockJones Day advised Oclaro, Inc. in its $1.8 billion acquisition by Lumentum Holdings Inc.
  • City of Hope collaborates with Intervention Insights to advance precision medicine in oncologyJones Day advised City of Hope, a world-renowned independent cancer research and treatment center, on a collaboration with Intervention Insights to advance the appropriate use of precision medicine in oncology.
  • Palestras / Aulas

    • December 3, 2009
      Intellectual Property at Home and Abroad
    *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.